Global Peripheral Nerve Injuries Market Research Report 2024

Publication ID:

PB504251635

Publication Date:

April 16, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Peripheral nerves can be damaged in several ways:听Injury from an accident, a fall or sports, which can stretch, compress, crush or cut nerves.
The global Peripheral Nerve Injuries market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Peripheral Nerve Injuries, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Nerve Injuries.
Report Scope
The Peripheral Nerve Injuries market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peripheral Nerve Injuries market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Nerve Injuries companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AxoGen, Inc.
Stryker
Baxter International, Inc.
Polyganics BV
Integra Lifesciences Corp.
Renerva, LLC.
Medovent GmbH
Toyobo Co., Ltd.
Segment by Type
Nerve Conduit
Nerve Protector
Nerve Connector
Nerve Wraps
Segment by Application
Upper Extremities
Lower Extremities
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peripheral Nerve Injuries companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Nerve Injuries Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nerve Conduit
1.2.3 Nerve Protector
1.2.4 Nerve Connector
1.2.5 Nerve Wraps
1.3 Market by Application
1.3.1 Global Peripheral Nerve Injuries Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Upper Extremities
1.3.3 Lower Extremities
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Nerve Injuries Market Perspective (2019-2030)
2.2 Peripheral Nerve Injuries Growth Trends by Region
2.2.1 Global Peripheral Nerve Injuries Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Peripheral Nerve Injuries Historic Market Size by Region (2019-2024)
2.2.3 Peripheral Nerve Injuries Forecasted Market Size by Region (2025-2030)
2.3 Peripheral Nerve Injuries Market Dynamics
2.3.1 Peripheral Nerve Injuries Industry Trends
2.3.2 Peripheral Nerve Injuries Market Drivers
2.3.3 Peripheral Nerve Injuries Market Challenges
2.3.4 Peripheral Nerve Injuries Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Nerve Injuries Players by Revenue
3.1.1 Global Top Peripheral Nerve Injuries Players by Revenue (2019-2024)
3.1.2 Global Peripheral Nerve Injuries Revenue Market Share by Players (2019-2024)
3.2 Global Peripheral Nerve Injuries Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peripheral Nerve Injuries Revenue
3.4 Global Peripheral Nerve Injuries Market Concentration Ratio
3.4.1 Global Peripheral Nerve Injuries Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Nerve Injuries Revenue in 2023
3.5 Peripheral Nerve Injuries Key Players Head office and Area Served
3.6 Key Players Peripheral Nerve Injuries Product Solution and Service
3.7 Date of Enter into Peripheral Nerve Injuries Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Nerve Injuries Breakdown Data by Type
4.1 Global Peripheral Nerve Injuries Historic Market Size by Type (2019-2024)
4.2 Global Peripheral Nerve Injuries Forecasted Market Size by Type (2025-2030)
5 Peripheral Nerve Injuries Breakdown Data by Application
5.1 Global Peripheral Nerve Injuries Historic Market Size by Application (2019-2024)
5.2 Global Peripheral Nerve Injuries Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Peripheral Nerve Injuries Market Size (2019-2030)
6.2 North America Peripheral Nerve Injuries Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Peripheral Nerve Injuries Market Size by Country (2019-2024)
6.4 North America Peripheral Nerve Injuries Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peripheral Nerve Injuries Market Size (2019-2030)
7.2 Europe Peripheral Nerve Injuries Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Peripheral Nerve Injuries Market Size by Country (2019-2024)
7.4 Europe Peripheral Nerve Injuries Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Nerve Injuries Market Size (2019-2030)
8.2 Asia-Pacific Peripheral Nerve Injuries Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Peripheral Nerve Injuries Market Size by Region (2019-2024)
8.4 Asia-Pacific Peripheral Nerve Injuries Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peripheral Nerve Injuries Market Size (2019-2030)
9.2 Latin America Peripheral Nerve Injuries Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Peripheral Nerve Injuries Market Size by Country (2019-2024)
9.4 Latin America Peripheral Nerve Injuries Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Nerve Injuries Market Size (2019-2030)
10.2 Middle East & Africa Peripheral Nerve Injuries Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Peripheral Nerve Injuries Market Size by Country (2019-2024)
10.4 Middle East & Africa Peripheral Nerve Injuries Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AxoGen, Inc.
11.1.1 AxoGen, Inc. Company Detail
11.1.2 AxoGen, Inc. Business Overview
11.1.3 AxoGen, Inc. Peripheral Nerve Injuries Introduction
11.1.4 AxoGen, Inc. Revenue in Peripheral Nerve Injuries Business (2019-2024)
11.1.5 AxoGen, Inc. Recent Development
11.2 Stryker
11.2.1 Stryker Company Detail
11.2.2 Stryker Business Overview
11.2.3 Stryker Peripheral Nerve Injuries Introduction
11.2.4 Stryker Revenue in Peripheral Nerve Injuries Business (2019-2024)
11.2.5 Stryker Recent Development
11.3 Baxter International, Inc.
11.3.1 Baxter International, Inc. Company Detail
11.3.2 Baxter International, Inc. Business Overview
11.3.3 Baxter International, Inc. Peripheral Nerve Injuries Introduction
11.3.4 Baxter International, Inc. Revenue in Peripheral Nerve Injuries Business (2019-2024)
11.3.5 Baxter International, Inc. Recent Development
11.4 Polyganics BV
11.4.1 Polyganics BV Company Detail
11.4.2 Polyganics BV Business Overview
11.4.3 Polyganics BV Peripheral Nerve Injuries Introduction
11.4.4 Polyganics BV Revenue in Peripheral Nerve Injuries Business (2019-2024)
11.4.5 Polyganics BV Recent Development
11.5 Integra Lifesciences Corp.
11.5.1 Integra Lifesciences Corp. Company Detail
11.5.2 Integra Lifesciences Corp. Business Overview
11.5.3 Integra Lifesciences Corp. Peripheral Nerve Injuries Introduction
11.5.4 Integra Lifesciences Corp. Revenue in Peripheral Nerve Injuries Business (2019-2024)
11.5.5 Integra Lifesciences Corp. Recent Development
11.6 Renerva, LLC.
11.6.1 Renerva, LLC. Company Detail
11.6.2 Renerva, LLC. Business Overview
11.6.3 Renerva, LLC. Peripheral Nerve Injuries Introduction
11.6.4 Renerva, LLC. Revenue in Peripheral Nerve Injuries Business (2019-2024)
11.6.5 Renerva, LLC. Recent Development
11.7 Medovent GmbH
11.7.1 Medovent GmbH Company Detail
11.7.2 Medovent GmbH Business Overview
11.7.3 Medovent GmbH Peripheral Nerve Injuries Introduction
11.7.4 Medovent GmbH Revenue in Peripheral Nerve Injuries Business (2019-2024)
11.7.5 Medovent GmbH Recent Development
11.8 Toyobo Co., Ltd.
11.8.1 Toyobo Co., Ltd. Company Detail
11.8.2 Toyobo Co., Ltd. Business Overview
11.8.3 Toyobo Co., Ltd. Peripheral Nerve Injuries Introduction
11.8.4 Toyobo Co., Ltd. Revenue in Peripheral Nerve Injuries Business (2019-2024)
11.8.5 Toyobo Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

AxoGen, Inc.
Stryker
Baxter International, Inc.
Polyganics BV
Integra Lifesciences Corp.
Renerva, LLC.
Medovent GmbH
Toyobo Co., Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂